NCT02468570View on ClinicalTrials.gov

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

August 5, 2015

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Phenylketonuria
Interventions
OTHER

Administration of CANTAB and Subject Global Assessment

At designated visits, subject will perform the CANTAB tasks and complete the Subject Global Assessment Questionnaire

Trial Locations (4)

40536

University of Kentucky Medical Center, Lexington

68198

University of Nebraska Medical Center, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

97239

Oregon Health and Science University, Portland

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY